RobertKurmanMD

PubMed

• 8 citations
  Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety.
  Jaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, Julio C Reina, Punnee Pitisuttithum
  Pediatrics. 2023-10-01
• 1 citations
  Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.
  Charlotte G Hannibal, Louise Baandrup, Rasmus Hertzum-Larsen, Russell Vang, Robert J Kurman
  International Journal of Cancer. 2023-04-01
• 45 citations
  Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 t...
  Stephen E. Goldstone, Anna R. Giuliano, Joel M. Palefsky, Eduardo Lazcano-Ponce, Mary E. Penny
  The Lancet. Infectious Diseases. 2021-11-12

Journal Articles

• Evaluation of liquid from Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers  
  Cristian Tomasetti, Kenneth W. Kinzler, Bert Vogelstein, Amanda N. Fader, Lucy Gilbert, Nickolas Papadopoulos, Yuxuan Wang, Lu Li, Christopher Douville, Joshua D. Cohe..., Sci Transl Med, 1/1/2018
• Comprehensive Surgical Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas: Is it Necessary?  
  Padhy RR,�Savage J,�Kurman RJ, Int J Gynecol Pathol, 1/1/2018
• The long term behavior of serous borderline tumors supports dividing them into atypical proliferative serous tumors and noninvasive low-grade serous carcinomas: A clin...  
  Vang R, Gerd Hannibal C, Junge J, Frederiksen K, Kjaer, SK, Kurman RJ, Am J Surg Pathol, 1/1/2017
• Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors A potential mechanism in ovarian tumorigenesis  
  Blanco Jr L, Kuhn E, Morrison J, Bahadirli-Talbott A, Smith Sehdev A, and Kurman RJ, Mod Pathol, 1/1/2017
• Atypical proliferative (borderline) serous ytumor in the brain A case report  
  Xing, D, Jenson, EG, Christopher, A, Zwick, CA, Fausto, MJ, Rodriguez, J, Kurman RJ, Int J Gynecol Pathol, 1/1/2017
• Diagnostic potential of umor DNA from ovarian cyst fluid  
  Wang Y, Sundfeldt K, Mateoiu C, Shih I-M, Kurman RJ, Schaeffer J, Silliman N, Kinde I, Simeon Springer, Michael Foote, Bj�rg Kristjansdottir, Nathan James, Kenneth W. ..., eLife, 1/1/2016
• CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor ov ovarian high-gr...  
  Kuhn E, Wang T-L, Doberstein K, Bahadirli-Talbott A, Ayhan A, Smith Sedhev A, Drapkin R, Kurman RJ, Shih I-M, Mod Pathol, 1/1/2016
• PD-L1 expression in human placentas and gestational trophoblastic disease  
  Veras E, Kurman RJ, Wang T-L, Shih I-M, Int J Gynnecol Pathol, 1/1/2016
• The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised and Expanded  
  Kurman RJ, Shih I-M, Am J Pathol, 1/1/2016
• Seromucinous tumors of the ovary What�s in a name?  
  Kurman RJ, Shih I-M, Int J Gynecol Pathol, 1/1/2016
• Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin  
  Wang Y, Wu R-C, Lauren Ende Shwartz, LE, Haley L, Lin MT, Shih I-M, Kurman RJ, J Pathol, 1/1/2015
• Molecular analysis of ovarian mucinous carcinoma reveals different cell of origins  
  Wang Y, Shwartz LE, Anderson D, Lin M-T, Haley L, Wu R-C, Shih I-M, Kurman RJ, Oncotarget, 1/1/2015
• Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a re-review of cases lacking TP53 mutations in The Cancer Genome Atlas Ova...  
  Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IM, Kurman RJ, Int J Gynecol Pathol, 1/1/2015
• Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy  
  Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ, Gynecologic Oncology, 1/1/2014
• Ki-67 as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change  
  Gurda GT, Baras AS, Kurman RJ, Int J Gynecol Pathol, 1/1/2014
• The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis  
  Kuhn E, Ayhan A, Shih I-M, Seidman JD, Kurman RJ, Mod Pathol, 1/1/2014
• Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors  
  Maniar KP, Wang Y, Visvanathan K, Shih I-M, Kurman RJ, Am J Surg Pathol, 1/1/2014
• A nationwide study of serous �borderline� ovarian tumors in Denmark 1978-2002: Centralized pathology review and overall survival compared to the general population  
  Hannibal CG, Vang R, Junge J, Frederiksen K, Kyaerbye-Thygesen A, Kaae Andersen K, Tabor A, Kurman RJ, Kjaer SK, Gynecologic Oncology, 1/1/2014
• A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development  
  Sherman-Baust CA1, Kuhn E, Valle BL, Shih IeM, Kurman RJ, Wang TL, Amano T, Ko MS, Miyoshi I, Araki Y, Lehrmann E, Zhang Y, Becker KG, Morin PJ, J Pathol, 1/1/2014
• Characterization of the immune cell repertoire in the normal fallopian tube  
  Ardighieri L, Lonardi S, Moratto D, Faccetti F, Shih I-M, Vermi W, Kurman RJ, Int J Gynecol Pathol, 1/1/2014
• Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants  
  Ardighieri L, Zeppernick F, Hannibal CG, Vang R, Cope L, Junge J, Kjaer SK, Kurman RJ, Shih IeM, J Pathol, 1/1/2014
• BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors  
  Zeppernick F, Ardighieri L, Hannibal CG, Vang R, Junge J, Kjaer SK, Zhang R, Kurman RJ, Shih, Ie-M, Am J Surg Pathol, 1/1/2014
• Types of ovarian inclusion cysts Proposed origina and possible role in ovarian serous carcinogenesis  
  Banet N, Kurman RJ, Int J Gynecol Pathol, 1/1/2014
• Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma  
  Nik NN, Vang RV, Shih I-M, Kurman RJ, Annu Rev Pathol Mech Dis, 1/1/2014
• Discovery of a cell: Reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations  
  Kurman RJ, Shih I-M, Int J Gynecol Pathol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Diagnosis of Endometrial Biopsies and Curettings. A Practical Approach 
  Murdock T, Veras E, Kurman RJ, Mazur MTSpringer-Verlag, New York, NYEdition 3rd,2019
• Blaustein's Pathology of the Female Genital Tract 
  Chapter: Epithelial Tumors of the Ovary 
  Page 841 - 966Robert KurmanEditors: Kurman, Ellenson, Ronnett.Springer Nature, Cham, Switzerland2015
• Sternberg�s Surgical Pathology volume 2 
  Chapter: Gestational trophoblastic disease 
  Page 2297 - 2319Shih I-M, Mazur MT, Kurman RJEditors: SE Mills, JK Greenson, JL Hornick, TA Longacre, VE Reuter.Wolters KluwerEdition 6th,2015
• World Health Organization Classification of Tumours, Tumours of Female Reproductive Organs, 
  Kurman RJ, Carcangiou ML, Herrington S, Young RHIARC Press, Lyon, FranceEdition 4th,2014
• Controversies in the Management of Gynecological Cancers 
  Chapter: New views of ovarian carcinoma types: How will this change practice? 
  Page 29 - 38Kobel M, Kurman RJ, Seidman JDEditors: J.A. Ledermann, et al.Springer-Verlag, London, United Kingdom2014
• Molelcular Surgical Pathology 
  Chapter: Molecular pathology of ovarian cancer 
  Page 129 - 149Maniar KP, Shih IM, Kurman RJEditors: Cheng L and JN Eble.Springer Science and Business Media2013
• Principles of Molecular Diagnostics and Personalized Cancer Medicine 
  Chapter: Molecular diagnostics of gynecologic neoplasms 
  Page 477 - 491Kurman RJ, Bagby CM, Shih Ie-MEditors: Chan D and Lynch HT.Lippincott Williams & Wilkins2013
• Textbook of Gynaecological Oncology 
  Chapter: The origin and pathogenesis of epithelial ovarian cancer 
  Page 422 - 431Banet N, Shih I-M, Kurman RJEditors: A Ayhan, N Reed, M Gultekin, P Dursun.Gunes Publishing, Turkey2012
• Molecular Genetic Pathology 
  Chapter: Molecular pathology of ovarian cancer 
  Maniar KP, Shih IM, Kurman RJEditors: Cheng L and Zhang D.Hanna Press2012
• Blaustein�s Pathology of the Female Genital Tract 
  Editors: Kurman RJ, L Hedrick Ellenson, BM Ronnett.Springer-Verlag, New York, NYEdition 6th,2011
• Atlas of Tumor Pathology. Tumors of the Cervix, Vagina and Vulva, Fourth Series, Fascicle 13 
  Kurman RJ, Ronnett BM, Sherman ME and Wilkinson EArmed Forces Institute of Pathology, Washington, DC2010
• Sternberg�s Diagnostic Surgical Pathology 
  Chapter: Gestational trophoblastic disease 
  Page 2049 - 2070Shih I-M, Mazur MT, Kurman RJEditors: Milles SE.Lippincott, Williams & WilkinsEdition 5th,2009
• Molecular Pathology of Gynecologic Cancer 
  Giordano A, Bovicelli A, Kurman RJHumana Press, Totowa, NJ2007
• Diagnosis of Endometrial Biopsies and Curettings. A Practical Approach 
  Mazur MT, Kurman RJSpringer-Verlag, New York, NYEdition 2nd,2005
• Borderline ovarian tumors: Key points and workshop summary 
  Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, Silva E, Gorstein F and Young RH2004
• WHO Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs 
  Chapter: Tumors of the uterine corpus: Epithelial tumors and related lesions 
  Page 221 - 232Silvergberg S, Mutter G, Kurman REditors: FA T, MR S.IARC Press, Lyon, FranceEdition 1st,2003
• Current Concepts in Ovarian Cancer 
  Chapter: Pathology of ovarian carcinoma 
  Page 909 - 925Seidman JD, Kurman RJEditors: ML Disis.Hematology Oncology Clinics of North America2003
• Blaustein�s Pathology of the Female Genital Tract 
  Editors: Kurman RJ.Springer-Verlag, New York, NYEdition 5th,2002
• Blaustein�s Pathology of the Female Genital Tract 
  Chapter: Surface epithelial tumors of the ovary 
  Page 791 - 904Seidman JD, Russell P, Kurman RJEditors: RJ Kurman.Springer-Verlag, New York, NYEdition 5th,2002
• Blaustein�s Pathology of the Female Genital Tract 
  Chapter: Precursor lesions of endometrial carcinoma 
  Page 467 - 500Ronnett BM, Kurman RJEditors: RJ Kurman.Springer-Verlag, New York, NYEdition 5th,2002
• Estrogens and Progestogens in Clinical Practice 
  Chapter: Progestogen therapy in malignant tumors of the uterus and ovary 
  Page 727 - 735Felix JC, Kurman RJEditors: IS Frazer, RPS Jansen, MI Whitehead.Churchill Livingstone, London, United Kingdom1998
• Anatomic Pathology 
  Chapter: Pseudomyxoma peritonei; new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (Low malignant potential) tumors of the ovary 
  Page 197 - 226Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJEditors: RE Fechner and PP Rosen.American Society of Clinical Pathologists, Chicago, IL1997
• Advances in Surgery 
  Chapter: Pseudomyxoma Peritonei Syndrome 
  Page 253 - 280Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, Dalton RR, Ettinghausen SE, Jacquet P, Jelinek J, Kislowe P, Kurman RJ, Shmookler B, Stephens AD, S...Editors: JL Cameron, et al.Mosby, St. Louis, MO1996
• Human Papillomaviruses I 
  Chapter: The role of exfoliative cytology and histopathology in screening and triage 
  Page 641 - 655Sherman ME, Kurman RJEditors: AT Lorincz and R Reid.W.B. Saunders Co., Philadelphia, PA1996
• Diagnosis of Endometrial Biopsies and Curettings. A Practical Approach 
  Mazur MT, Kurman RJSpringer-Verlag, New York, NY1995
• Join now to see all

Other

• Victor Velculescu. High grade serous ovarian carcinomas originate in the fallopian tube 
  Sana Labidi-Galy, Eniko Papp, Vilmos Adleff, Rohit Bhattacharya, Noushin Niknafs, Marian Novak, Sian Jones, Jillian Phallen, Carolyn Hruban, Michelle Hirsch, Douglas L..., Nature Communications
  1/1/2017
• Cervical Cytology: Evaluation and Management of Abnormalities 
  Kurman RJ, ACOG Technical Bulletin
  1/1/1993
• Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma 
  Ducie J, Dao F, Considine M, Olvera N, Shaw PA, Kurman RJ, Shih I-M, Soslow RA, Cope L, Levine DA, Nature Communications